234 related articles for article (PubMed ID: 33337557)
1. Emerging trends in chromatin remodeler plasticity in mesenchymal stromal cell function.
Chakraborty S; Sinha S; Sengupta A
FASEB J; 2021 Jan; 35(1):e21234. PubMed ID: 33337557
[TBL] [Abstract][Full Text] [Related]
2. Pbrm1 Steers Mesenchymal Stromal Cell Osteolineage Differentiation by Integrating PBAF-Dependent Chromatin Remodeling and BMP/TGF-β Signaling.
Sinha S; Biswas M; Chatterjee SS; Kumar S; Sengupta A
Cell Rep; 2020 Apr; 31(4):107570. PubMed ID: 32348751
[TBL] [Abstract][Full Text] [Related]
3. Chromatin dynamics regulate mesenchymal stem cell lineage specification and differentiation to osteogenesis.
Wu H; Gordon JA; Whitfield TW; Tai PW; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):438-449. PubMed ID: 28077316
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
5. Recent Trends in Multipotent Human Mesenchymal Stem/Stromal Cells: Learning from History and Advancing Clinical Applications.
Dzobo K
OMICS; 2021 Jun; 25(6):342-357. PubMed ID: 34115524
[TBL] [Abstract][Full Text] [Related]
6. DNA methyltransferases inhibitors effectively induce gene expression changes suggestive of cardiomyogenic differentiation of human amniotic fluid-derived mesenchymal stem cells via chromatin remodeling.
Gasiūnienė M; Zentelytė A; Wojtas B; Baronaitė S; Krasovskaja N; Savickienė J; Gielniewski B; Kaminska B; Utkus A; Navakauskienė R
J Tissue Eng Regen Med; 2019 Mar; 13(3):469-481. PubMed ID: 30637987
[TBL] [Abstract][Full Text] [Related]
7. The Chromatin Remodeling Complex CHD1 Regulates the Primitive State of Mesenchymal Stromal Cells to Control Their Stem Cell Supporting Activity.
Lee HR; Yang SJ; Choi HK; Kim JA; Oh IH
Stem Cells Dev; 2021 Apr; 30(7):363-373. PubMed ID: 33593142
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells: radio-resistant members of the bone marrow.
Sugrue T; Lowndes NF; Ceredig R
Immunol Cell Biol; 2013 Jan; 91(1):5-11. PubMed ID: 23165606
[TBL] [Abstract][Full Text] [Related]
9. Сord blood hematopoietic stem cells ex vivo enhance the bipotential commitment of adipose mesenchymal stromal progenitors.
Buravkova LB; Ezdakova MI; Andrianova IV; Gornostaeva AN; Bobyleva PI; Andreeva ER
Life Sci; 2021 Mar; 268():118970. PubMed ID: 33383051
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stromal Cell-derived Extracellular Vesicles Promote Myeloid-biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement.
Goloviznina NA; Verghese SC; Yoon YM; Taratula O; Marks DL; Kurre P
J Biol Chem; 2016 Nov; 291(47):24607-24617. PubMed ID: 27758863
[TBL] [Abstract][Full Text] [Related]
11. De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins.
Squillaro T; Severino V; Alessio N; Farina A; Di Bernardo G; Cipollaro M; Peluso G; Chambery A; Galderisi U
Cell Cycle; 2015; 14(8):1315-26. PubMed ID: 25724006
[TBL] [Abstract][Full Text] [Related]
12. Murine Mesenchymal Stromal Cells Retain Biased Differentiation Plasticity Towards Their Tissue of Origin.
Ng TT; Mak KH; Popp C; Ng RK
Cells; 2020 Mar; 9(3):. PubMed ID: 32204552
[TBL] [Abstract][Full Text] [Related]
13. Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications.
Kim N; Cho SG
Int J Hematol; 2016 Feb; 103(2):129-37. PubMed ID: 26662288
[TBL] [Abstract][Full Text] [Related]
14. Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixafor.
Ludwig A; Saffrich R; Eckstein V; Bruckner T; Wagner W; Ho AD; Wuchter P
Cytotherapy; 2014 Jan; 16(1):111-21. PubMed ID: 24119647
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk.
Fattizzo B; Giannotta JA; Barcellini W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751628
[TBL] [Abstract][Full Text] [Related]
16. An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program.
Gnani D; Crippa S; Della Volpe L; Rossella V; Conti A; Lettera E; Rivis S; Ometti M; Fraschini G; Bernardo ME; Di Micco R
Aging Cell; 2019 Jun; 18(3):e12933. PubMed ID: 30828977
[TBL] [Abstract][Full Text] [Related]
17. TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis.
Klamer SE; Dorland YL; Kleijer M; Geerts D; Lento WE; van der Schoot CE; von Lindern M; Voermans C
Stem Cells Dev; 2018 Nov; 27(21):1494-1506. PubMed ID: 30084753
[TBL] [Abstract][Full Text] [Related]
18. Shift of EMT gradient in 3D spheroid MSCs for activation of mesenchymal niche function.
Jeon S; Lee HS; Lee GY; Park G; Kim TM; Shin J; Lee C; Oh IH
Sci Rep; 2017 Jul; 7(1):6859. PubMed ID: 28761088
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Regulators of Mesenchymal Stem/Stromal Cell Lineage Determination.
Cakouros D; Gronthos S
Curr Osteoporos Rep; 2020 Oct; 18(5):597-605. PubMed ID: 32794139
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulatory properties of mesenchymal stem cells.
Marigo I; Dazzi F
Semin Immunopathol; 2011 Nov; 33(6):593-602. PubMed ID: 21499984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
